-+ 0.00%
-+ 0.00%
-+ 0.00%

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 30, 2026 in Anavex Life Sciences Corp. Lawsuit - AVXL

Barchart·10/08/2026 09:11:00
Listen to the news

The Red Flags: What Insiders Allegedly Knew Before Shareholders Did. Anavex now says its Board reviews and executive certifications could operate on incomplete information, and it has told investors to rely only on its revised clinical trial descriptions.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.